Posted by Michael Wonder on 07 Apr 2022
COVID-19 vaccine weekly safety report (7 April 2022)
7 April 2022 - To 3 April 2022, the TGA has received 511 reports which have been assessed as likely to be myocarditis from about 38.7 million doses of Comirnaty (Pfizer) and 82 reports which have been assessed as likely to be myocarditis from about 4 million doses of Spikevax (Moderna).
No new cases of vaccine related thrombosis with thrombocytopenia syndrome have been reported this year.
